Lineage Cell Therapeutics (LCTX) Total Debt (2014 - 2021)

Lineage Cell Therapeutics (LCTX) reported Total Debt of $523000.0 for Q1 2021, little changed quarter-over-quarter from $523000.0 in Q4 2020.

Lineage Cell Therapeutics (LCTX) Total Debt (2014 - 2021) Analysis & Trends

Lineage Cell Therapeutics has reported Total Debt for 6 years, with the latest figure at $523000.0 in Q1 2021.

  • For the quarter ending Q1 2021, Total Debt changed N/A year-over-year to $523000.0; the trailing twelve-month figure through Mar 2021 stood at $523000.0 (changed N/A YoY), and the FY2020 full-year result was $523000.0, changed N/A from the prior year.
  • Total Debt for Q1 2021 stood at $523000.0, roughly flat from $523000.0 in the prior quarter.
  • The five-year high for Total Debt was $523000.0 in Q2 2020, with the low at $18000.0 in Q4 2017.
  • Historically, Total Debt has averaged $293000.0 across 3 years, with a median of $309000.0 in 2017.
  • The largest YoY upside for Total Debt was 45.09% in 2017 against a maximum downside of 85.0% in 2017.
  • Lineage Cell Therapeutics' Total Debt stood at $18000.0 in 2017, then jumped by 2805.56% to $523000.0 in 2020, then changed by 0.0% to $523000.0 in 2021.
  • The last three Total Debt figures came in at $523000.0 (Q1 2021), $523000.0 (Q4 2020), and $523000.0 (Q3 2020), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 319.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -
9 Abivax 91.96 Bn 91.96 Bn - -
10 Lineage Cell Therapeutics 303.84 Mn 239.94 Mn 1.73 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2021 523,000.00
Dec 31, 2020 523,000.00
Sep 30, 2020 523,000.00
Jun 30, 2020 523,000.00
Dec 31, 2017 18,000.00
Sep 30, 2017 44,000.00
Jun 30, 2017 95,000.00
Mar 31, 2017 95,000.00
Dec 31, 2016 120,000.00
Sep 30, 2016 173,000.00
Jun 30, 2016 173,000.00
Mar 31, 2016 220,000.00
Dec 31, 2015 246,000.00
Sep 30, 2015 268,000.00
Jun 30, 2015 3,000.00
Mar 31, 2015 17,307.00
Dec 31, 2014 31,000.00
Sep 30, 2014 44,963.00
Jun 30, 2014 57,500.00